Cargando…

Treatment evolution and improved survival in multiple myeloma in Taiwan

The incidence of multiple myeloma (MM) is increasing worldwide, but the rate of increase is greatest in Asia. Few data describe the epidemiology and treatment of MM in Asia. Building on a cohort study from 2007 to 2012 using the Taiwan National Healthcare Insurance Research database, we extended our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Chao-Hsiun, Hou, Hsin-An, Huang, Kuan-Chih, Qiu, Hong, Liu, Yanfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976543/ https://www.ncbi.nlm.nih.gov/pubmed/31802187 http://dx.doi.org/10.1007/s00277-019-03858-w

Ejemplares similares

Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2021)

Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
por: Liu, Yanfang, et al.
Publicado: (2020)

A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan
por: Hou, Hsin-An, et al.
Publicado: (2022)

The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan
por: Herr, Keira Joann, et al.
Publicado: (2023)

Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
por: Chen, Jia-Hong, et al.
Publicado: (2016)

Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan
por: Cheng, Chih-Ning, et al.
Publicado: (2021)

Healthcare resource utilization and costs associated with generalized myasthenia gravis: a retrospective matched cohort study using the National Health Insurance Research Database in Taiwan
por: Shen, Shih-Pei, et al.
Publicado: (2023)

Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
por: Li, Ko-Jen, et al.
Publicado: (2021)

Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2021)

Persistence and Adherence to Biologics in Patients with Psoriasis in Taiwan: A New Biologics User Cohort Study
por: Huang, Yu-Huei, et al.
Publicado: (2022)

Chinese Herbal Medicine Is Helpful for Survival Improvement in Patients With Multiple Myeloma in Taiwan: A Nationwide Retrospective Matched-Cohort Study
por: Huang, Chia-Yu, et al.
Publicado: (2020)

Healthcare resource utilization and costs among patients with rheumatoid arthritis on biologic therapies in Taiwan: A 1-year mirror-image study using a national claims database
por: Chen, Kuan-Chen, et al.
Publicado: (2018)

Tumefactive Multiple Sclerosis in Taiwan
por: Kuan, Yi-Chun, et al.
Publicado: (2013)

Do Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis Have the Same Clinical Outcomes? A Ten-year Cohort Study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2016)

Time Trend of Multiple Myeloma and Associated Secondary Primary Malignancies in Asian Patients: A Taiwan Population–Based Study
por: Tzeng, Huey-En, et al.
Publicado: (2013)

Recognizing spatial and temporal clustering patterns of dengue outbreaks in Taiwan
por: Lai, Wei-Ting, et al.
Publicado: (2018)

Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan
por: Chen, Yong-Chen, et al.
Publicado: (2012)

Treatment adherence among new triptan users: a 2-year cohort study in Taiwan
por: Chen, Ting-Bin, et al.
Publicado: (2014)

Economic Burden of Atopic Dermatitis in Taiwan
por: LEE, Ellen M., et al.
Publicado: (2023)

Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan
por: CHAN, Tom C., et al.
Publicado: (2021)

The Evolution of Prognostic Factors in Multiple Myeloma
por: Hanbali, Amr, et al.
Publicado: (2017)

Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma
por: Puertas, Borja, et al.
Publicado: (2023)

Long-term survival in multiple myeloma
por: João, Cristina, et al.
Publicado: (2014)

Evolution of Treatment Regimens in Multiple Myeloma: A Social Network Analysis
por: Mahony, Helen, et al.
Publicado: (2014)

Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma
por: Suzuki, Kazuhito, et al.
Publicado: (2021)

A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
por: Botta, C, et al.
Publicado: (2016)

The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan
por: Liu, Jiung-Hsiun, et al.
Publicado: (2012)

Prevalence of baseline comorbidities in patients with atopic dermatitis: A population-based cohort study in Taiwan
por: Cho, Yung-Tsu, et al.
Publicado: (2020)

Socioeconomic Factors and Survival of Multiple Myeloma Patients
por: Chamoun, Kamal, et al.
Publicado: (2021)

Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan
por: Chen, Der-Yuan, et al.
Publicado: (2019)

Survival rate in nasopharyngeal carcinoma improved by high caseload volume: a nationwide population-based study in Taiwan
por: Lee, Ching-Chih, et al.
Publicado: (2011)

Clinical Manifestations of Bacteremia Caused by Aeromonas Species in Southern Taiwan
por: Tang, Hung-Jen, et al.
Publicado: (2014)

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
por: Bolli, Niccolo, et al.
Publicado: (2014)

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2021)

Molecular and immunological mechanisms of clonal evolution in multiple myeloma
por: Forster, Stefan, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
por: Kumar, Shaji K., et al.
Publicado: (2013)

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
por: Gonsalves, W I, et al.
Publicado: (2015)

Beta‐blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
por: Hwa, Yi L., et al.
Publicado: (2016)

30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma
por: Chacon, Aurelia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s6img9m28kp2c9om5kq4kc85lj